CNR Institutional Research Information System

MELILLO, ROSA MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 338
AS - Asia 152
EU - Europa 51
AF - Africa 2
SA - Sud America 1
Totale 544
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 337
SG - Singapore 132
IT - Italia 18
FI - Finlandia 12
CN - Cina 10
DE - Germania 7
HU - Ungheria 4
NL - Olanda 4
AT - Austria 2
KR - Corea 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CA - Canada 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HK - Hong Kong 1
IE - Irlanda 1
IL - Israele 1
IN - India 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
PH - Filippine 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 544
Salva come PNG Salva come JPEG
Città #
Santa Clara 287
Singapore 62
Helsinki 12
Los Angeles 5
Falkenstein 4
Florence 4
Rome 4
Naples 2
San Nicola Manfredi 2
Seoul 2
Vienna 2
Ashburn 1
Avellino 1
Baku 1
Bishkek 1
Boardman 1
Colombo 1
Dublin 1
Fort Worth 1
Guayaquil 1
Hong Kong 1
Indore 1
Lisbon 1
Luxembourg 1
Manila 1
Montreal 1
New York 1
Newark 1
Palermo 1
Phoenix 1
Prague 1
Seattle 1
Sopron 1
Springfield 1
Tel Aviv 1
Totale 410
Salva come PNG Salva come JPEG
Nome #
Glucose Enhances Pro-Tumorigenic Functions of Mammary Adipose-Derived Mesenchymal Stromal/Stem Cells on Breast Cancer Cell Lines 18
Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as Melanoma and Lung Cancer 15
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. 15
Genetics: The genomic landscape of papillary thyroid carcinoma 14
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1). 14
Biochemical and molecular characterization of the novel BRAF V599Ins mutation detected in a classic papillary thyroid carcinoma 14
Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells. 14
Indoleamine 2,3-Dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment 13
The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins. 13
RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. 13
The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma 12
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. 11
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas. 11
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. 11
Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway. 11
Recent advances in understanding immune phenotypes of thyroid carcinomas: prognostication and emerging therapies 10
Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents 10
BRAF is a therapeutic target in aggressive thyroid carcinoma. 10
RET/PTC activation in human thyroid carcinomas 10
Multiple anti-tumor effects of Reparixin on thyroid cancer 9
RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2). 9
Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth 9
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. 9
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). 8
Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells 8
Inflammation in thyroid oncogenesis. 8
The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness 8
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. 8
Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways 8
Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. 8
The RET receptor family 8
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 8
Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase. 8
AXL is a novel predictive factor and therapeutic target for radioactive iodine refractory thyroid cancer 8
RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors. 8
L'osteopontina: un nuovo marcatore biologico dei carcinomi della testa e del collo 7
New perspectives in cancer: Modulation of lipid metabolism and inflammation resolution 7
The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis. 7
Role of Formyl Peptide Receptors In Gastrointestinal Healing. 7
XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway. 7
Genetic alterations in differentiated thyroid cancer: what can be expected for gene expression profiling of thyroid carcinomas 6
Ret-mediated mitogenesis requires Src kinase activity 6
Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells. 6
AXL is an oncotarget in human colorectal cancer 6
Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes 6
Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer 6
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. 6
Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKs): Evidence for a divergence of the ERKs and JNKs pathways induced by Ret 6
Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. 6
Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation 6
OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. 6
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture 6
Molecular biology of the MEN2 gene 6
Glial cell line-Derived Neurotrophic Factor differentially stimulates Ret mutants associated with the Multiple Endocrine Neoplasia type 2 syndromes and Hirschsprung's disease 6
The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. 6
Different mutations of the RET gene cause different human tumoral diseases 6
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 6
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenic mechanism of multiple endocrine neoplasia type 2B 6
Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors. 5
RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho. 5
The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. 5
Dysfunction of the RET receptor in human cancer. 5
Minireview: RET: normal and abnormal functions 5
Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension 5
Molecular biomarkers in thyroid FNA samples 5
The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway. 4
Activation of the Erk8 MAP kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene 4
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma. 4
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. 4
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters. 3
Mast cells have a protumorigenic role in human thyroid cancer. 3
Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. 3
Totale 574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.357
article - articoli 2.284
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 39
Totale 4.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 2 0 9 1
2024/2025562 3 3 66 44 271 47 16 79 33 0 0 0
Totale 574